Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Sep 2020

Code : CMI1072

Pages :181

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Organ Preservation Solutions Market: Restraints

Advent of stem cells is expected to hinder growth of the global organ preservation solutions market. The need for organ transplantation could ultimately be reduced by stem cell therapies. Scientists hope to repair/replace damaged organs with new cells grown from adult or embryonic stem cells. Therefore, increasing adoption of stem cell therapies could act as a restraint on the growth of the global organ preservation solutions market in the near future.

Moreover, high cost of the procedure is also expected to limit the growth of the global organ preservation solutions market. The cost of a kidney transplant procedure in the U.S. is around US$ 89,939. This is followed by medications for several years that cost around US$ 16,043 per year.

Global Organ Preservation Solutions Market: Opportunities

Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global organ preservation market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.

Moreover, favorable reimbursement scenarios are also expected to aid in the growth of the global organ preservation market. Currently, almost every transplant procedure is covered under an insurance plan either via Medicare (government insurance) or private insurance players in countries such as the U.S., India, Japan, and the U.K.